ArticleCureus2025
Low-Dose Radiation Therapy (LDRT) for Lymphatic Obliteration in Persistent Chylous Ascites: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chylous ascites is a rare postoperative complication, typically associated with extensive abdominal procedures and caused by inadvertent injury to the retroperitoneal lymphatic vessels. Its management represents a therapeutic challenge, particularly in cases refractory to conventional strategies. We present the case of a patient with persistent lymphatic leakage following retroperitoneal lymphadenectomy for recurrent testicular cancer, who failed multiple standard interventions. Given the refractory nature of the condition, low-dose external beam radiotherapy was administered, resulting in complete resolution with no recurrence at two-year follow-up. This case highlights radiotherapy as a potentially effective therapeutic option for the management of lymphatic fistulas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.